0HZC Stock Overview
A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Eurazeo SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €67.75 |
| 52 Week High | €81.05 |
| 52 Week Low | €53.65 |
| Beta | 1.31 |
| 1 Month Change | 16.11% |
| 3 Month Change | -15.76% |
| 1 Year Change | -13.00% |
| 3 Year Change | -4.96% |
| 5 Year Change | 58.96% |
| Change since IPO | 17.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HZC | GB Diversified Financial | GB Market | |
|---|---|---|---|
| 7D | -1.3% | 2.5% | 1.1% |
| 1Y | -13.0% | 13.7% | 0.8% |
Return vs Industry: 0HZC underperformed the UK Diversified Financial industry which returned 12.8% over the past year.
Return vs Market: 0HZC underperformed the UK Market which returned 0.7% over the past year.
Price Volatility
| 0HZC volatility | |
|---|---|
| 0HZC Average Weekly Movement | 5.2% |
| Diversified Financial Industry Average Movement | 5.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: 0HZC has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HZC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 549 | Christophe Baviere | www.eurazeo.com/en |
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors.
Eurazeo SE Fundamentals Summary
| 0HZC fundamental statistics | |
|---|---|
| Market cap | €4.69b |
| Earnings (TTM) | -€429.79m |
| Revenue (TTM) | €5.90m |
Is 0HZC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HZC income statement (TTM) | |
|---|---|
| Revenue | €5.90m |
| Cost of Revenue | €96.86m |
| Gross Profit | -€90.95m |
| Other Expenses | €338.83m |
| Earnings | -€429.79m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jul 24, 2025
| Earnings per share (EPS) | -6.21 |
| Gross Margin | -1,541.33% |
| Net Profit Margin | -7,283.27% |
| Debt/Equity Ratio | 17.9% |
How did 0HZC perform over the long term?
See historical performance and comparisonDividends
Does 0HZC pay a reliable dividends?
See 0HZC dividend history and benchmarks| Eurazeo dividend dates | |
|---|---|
| Ex Dividend Date | May 26 2025 |
| Dividend Pay Date | May 28 2025 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 7 days |
Does 0HZC pay a reliable dividends?
See 0HZC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 10:06 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eurazeo SE is covered by 13 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pierre-Yves Gauthier | AlphaValue |
| Christoph Greulich | Berenberg |
| Arnaud Maurice Giblat | BNP Paribas Exane |